These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2526136)

  • 21. Limitations in the use of insulin or C-peptide alone in the assessment of beta-cell function in pancreas transplant recipients. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation.
    Christiansen E; Tibell A; Groth CG; Rasmussen K; Pedersen O; Burcharth F; Christensen NJ; Vølund A; Madsbad S
    Transplant Proc; 1994 Apr; 26(2):467-8. PubMed ID: 8171508
    [No Abstract]   [Full Text] [Related]  

  • 22. 2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR).
    CITR Research Group
    Cell Transplant; 2009; 18(7):753-67. PubMed ID: 19796497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?
    Stadler M; Anderwald C; Karer T; Tura A; Kästenbauer T; Auinger M; Bieglmayer C; Wagner O; Kronenberg F; Nowotny P; Pacini G; Prager R
    Diabetes Care; 2006 May; 29(5):1031-8. PubMed ID: 16644633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postabsorptive muscle protein metabolism in type 1 diabetic patients after pancreas transplantation.
    Luzi L; Piceni Sereni L; Spessot M; Dodesini R; Pastore MR; Bianchi E; Terruzzi I; Secchi A; Cristallo M; Pozza G; Di Carlo V
    Acta Diabetol; 2000; 37(4):219-24. PubMed ID: 11450507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet allotransplantation in type I diabetic patients: effects of islet cell number on clinical outcome.
    Secchi A; Socci C; Maffi P; Falqui L; Bertuzzi F; De Nittis P; Piemonti L; Taglietti MV; Di Carlo V; Pozza G
    Transplant Proc; 1996 Oct; 28(5):2861-5. PubMed ID: 8908102
    [No Abstract]   [Full Text] [Related]  

  • 26. Continued insulin dependence despite normal insulin sensitivity and graft insulin secretion in a kidney/islet transplant patient.
    Atkison P; Zucker P; Hramiak I; Paul T; McCallum J; Stiller C; Sharp D; Lacy P; Olack B; Finegood D
    Transplant Proc; 1994 Apr; 26(2):573. PubMed ID: 8171560
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin independence after islet transplantation into type I diabetic patient.
    Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Falqui L; Marchetti P; Gingerich RL; Jaffe AS; Cryer PE
    Diabetes; 1990 Apr; 39(4):515-8. PubMed ID: 2108071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten years' clinical experience of fetal islet transplantation.
    Farkas G; Szabó M; Vörös P
    Transplant Proc; 1992 Dec; 24(6):2954-5. PubMed ID: 1466012
    [No Abstract]   [Full Text] [Related]  

  • 29. Intraportal islet allografts in type I diabetes mellitus.
    Alejandro R; Burke G; Shapiro ET; Strasser S; Nery J; Ricordi C; Esquenazi V; Miller J; Mintz DH
    Transplant Proc; 1992 Jun; 24(3):959-60. PubMed ID: 1604685
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical determinants of glucose homeostasis after pancreas transplantation.
    Nankivell BJ; Chapman JR; Bovington KJ; Spicer ST; O'Connell PJ; Allen RD
    Transplantation; 1996 Jun; 61(12):1705-11. PubMed ID: 8685947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant.
    Iwanaga Y; Matsumoto S; Okitsu T; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Fukuda K; Tsukiyama K; Tanaka K
    Ann N Y Acad Sci; 2006 Oct; 1079():335-9. PubMed ID: 17130575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial glycosylated hemoglobin levels in diabetic recipients of pancreatic transplants.
    Morel P; Goetz F; Moudry-Munns K; Freier E; Sutherland DE
    Transplant Proc; 1990 Apr; 22(2):649-50. PubMed ID: 2183435
    [No Abstract]   [Full Text] [Related]  

  • 33. Pancreatic islet-like clusters from bone marrow mesenchymal stem cells of human first-trimester abortus can cure streptozocin-induced mouse diabetes.
    Zhang Y; Shen W; Hua J; Lei A; Lv C; Wang H; Yang C; Gao Z; Dou Z
    Rejuvenation Res; 2010 Dec; 13(6):695-706. PubMed ID: 21204652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of human fetal pancreas after one year of implantation in the diabetic patient.
    Tuch BE; Sheil AG; Ng AB; Trent RJ; Turtle JR
    Transplantation; 1988 Dec; 46(6):865-70. PubMed ID: 2905087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000). Groupe de Recherche Rhin Rhĵne Alpes Genève pour la transplantation d'Ilots de Langerhans.
    Benhamou PY; Oberholzer J; Toso C; Kessler L; Penfornis A; Bayle F; Thivolet C; Martin X; Ris F; Badet L; Colin C; Morel P;
    Diabetologia; 2001 Jul; 44(7):859-64. PubMed ID: 11508270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network.
    Borot S; Niclauss N; Wojtusciszyn A; Brault C; Demuylder-Mischler S; Müller Y; Giovannoni L; Parnaud G; Meier R; Badet L; Bayle F; Frimat L; Kessler L; Morelon E; Penfornis A; Thivolet C; Toso C; Morel P; Bosco D; Colin C; Benhamou PY; Berney T;
    Transplantation; 2011 Nov; 92(9):1031-8. PubMed ID: 21926944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
    Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
    N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human fetal pancreatic islet transplantation in insulin-dependent diabetics: possibilities of early detection of transplant destruction].
    Djordjević PB; Brkić S; Lalić NM; Zamaklar M; Dragasević M; Radović Z; Popović S; Banović D; Dimitrijević V; Savić K
    Glas Srp Akad Nauka Med; 1994; (44):83-8. PubMed ID: 7590418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival.
    Deng S; Markmann JF; Rickels M; Yeh H; Kim JI; Lian MM; Gu Y; Markmann E; Palanjian M; Barker CF; Naji A
    Transplantation; 2009 Sep; 88(6):820-5. PubMed ID: 19920782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term metabolic and immunological follow-up of nonimmunosuppressed patients with type 1 diabetes treated with microencapsulated islet allografts: four cases.
    Basta G; Montanucci P; Luca G; Boselli C; Noya G; Barbaro B; Qi M; Kinzer KP; Oberholzer J; Calafiore R
    Diabetes Care; 2011 Nov; 34(11):2406-9. PubMed ID: 21926290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.